FDA — authorised 11 December 2018
- Application: NDA208901
- Marketing authorisation holder: MAYNE PHARMA
- Local brand name: TOLSURA
- Indication: CAPSULE — ORAL
- Status: approved
FDA authorised Tolsura on 11 December 2018
Yes. FDA authorised it on 11 December 2018.
MAYNE PHARMA holds the US marketing authorisation.